Albany Molecular Research Inc
AMRI
AMRI was delisted on the 31st of August, 2017.
151 hedge funds and large institutions have $622M invested in Albany Molecular Research Inc in 2015 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 64 increasing their positions, 36 reducing their positions, and 11 closing their positions.
103% more call options, than puts
Call options by funds: $520K | Put options by funds: $256K
82% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 11
78% more repeat investments, than reductions
Existing positions increased: 64 | Existing positions reduced: 36
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
12% more capital invested
Capital invested by funds: $556M → $622M (+$66.1M)
6% more funds holding
Funds holding: 143 → 151 (+8)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$5.27M |
| 2 |
PCM
Palisade Capital Management
Fort Lee,
New Jersey
|
+$3.27M |
| 3 |
ACM
American Capital Management
New York
|
+$3.11M |
| 4 |
RHJA
Rice Hall James & Associates
San Diego,
California
|
+$3.07M |
| 5 |
JP Morgan Chase
New York
|
+$2.98M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VAM
Visium Asset Management
New York
|
-$22.8M |
| 2 |
PIP
Permian Investment Partners
Dallas,
Texas
|
-$5.81M |
| 3 |
Morgan Stanley
New York
|
-$5.41M |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$4.45M |
| 5 |
HA
Heartland Advisors
Milwaukee,
Wisconsin
|
-$4.18M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
HA
151
Heartland Advisors
Milwaukee,
Wisconsin
| – | -$4.18M | -240,243 | Closed |
|
|
TI
152
Trexquant Investment
Stamford,
Connecticut
| – | -$813K | -46,700 | Closed |
|
|
SCA
153
STALEY CAPITAL ADVISERS
Pittsburgh,
Pennsylvania
| – | -$523K | -30,000 | Closed |
|
|
BMCMI
154
Bryn Mawr Capital Management Inc
Bryn Mawr,
Pennsylvania
| – | -$450K | -25,848 | Closed |
|
|
SCM
155
Stevens Capital Management
Radnor,
Pennsylvania
| – | -$346K | -19,838 | Closed |
|
|
PCM
156
Prelude Capital Management
New York
| – | -$331K | -19,000 | Closed |
|
157
AQR Capital Management
Greenwich,
Connecticut
| – | -$230K | -13,212 | Closed |
|
158
Nomura Holdings
Tokyo,
Japan
| – | -$200K | -11,400 | Closed |
|
|
SI
159
SII Investments
Appleton,
Wisconsin
| – | -$186K | -10,695 | Closed |
|
160
Daiwa Securities Group
Tokyo,
Japan
| – | -$38K | -500 | Closed |
|
|
BBHC
161
Brown Brothers Harriman & Co
New York
| – | -$3K | -150 | Closed |
|
162
Citigroup
New York
| – | +$285 | +15 | +375% |
|
AMRI Hedge Fund Activity: Q4 2015 in Review
151 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Albany Molecular Research Inc (AMRI) for Q4 2015, worth a combined $622M — up 12% from $556M a quarter earlier.
Buyers outnumbered sellers: 20 funds opened new AMRI positions and 11 closed out — a net gain of 9 holders — while 64 added to existing stakes and 36 trimmed.
The largest buyer was Oxford Asset Management, opening a new position worth an estimated $5.27M. The largest seller was Visium Asset Management, cutting an estimated $22.8M.
- 151 institutional investors held Albany Molecular Research Inc (AMRI) as of Q4 2015, up from 143 in Q3 2015.
- Funds reported $622M of Albany Molecular Research Inc stock for Q4 2015, up 12% quarter-over-quarter.
- 20 funds opened new Albany Molecular Research Inc positions in Q4 2015 and 11 closed out, a net change of +9 holders.
- The largest Albany Molecular Research Inc buyer in Q4 2015 was Oxford Asset Management, an estimated $5.27M added.
- The largest Albany Molecular Research Inc seller in Q4 2015 was Visium Asset Management, an estimated $22.8M sold.
Based on aggregated 13F filings for Q4 2015.